Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Raskob, Gary
One or more keywords matched the following items that are connected to Raskob, Gary
Item TypeName
Concept Hemorrhage
Concept Gastrointestinal Hemorrhage
Concept Postoperative Hemorrhage
Concept Intracranial Hemorrhages
Concept Cerebral Hemorrhage
Academic Article Hemorrhagic complications of anticoagulant treatment.
Academic Article Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
Academic Article Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.
Academic Article Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
Academic Article Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
Academic Article Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
Academic Article Oral rivaroxaban for symptomatic venous thromboembolism.
Academic Article Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
Academic Article Apixaban for extended treatment of venous thromboembolism.
Academic Article Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.
Academic Article Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
Academic Article Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trial.
Academic Article Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
Academic Article Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.
Academic Article Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
Academic Article Hemorrhagic complications of anticoagulant treatment.
Academic Article Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
Academic Article Hemorrhagic complications of long-term anticoagulant therapy.
Academic Article Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
Academic Article Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.
Academic Article Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
Academic Article Idraparinux versus standard therapy for venous thromboembolic disease.
Academic Article Extended prophylaxis of venous thromboembolism with idraparinux.
Academic Article Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
Academic Article Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
Academic Article Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
Academic Article Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
Academic Article Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
Academic Article Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Academic Article Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
Academic Article The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
Academic Article New paradigms in venous thromboprophylaxis of medically ill patients.
Academic Article Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
Academic Article Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.
Academic Article Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
Academic Article Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management.
Academic Article Aging and heparin-related bleeding.
Academic Article Different effects of heparin in males and females.
Academic Article Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Academic Article Prevention of central venous catheter-associated thrombosis: a meta-analysis.
Academic Article Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
Academic Article Hemorrhagic complications of long-term anticoagulant therapy.
Academic Article Oral apixaban for the treatment of acute venous thromboembolism.
Academic Article RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
Academic Article Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
Academic Article Hemorrhagic complications of anticoagulant treatment.
Academic Article Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests.
Academic Article Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
Academic Article Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Academic Article A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
Academic Article A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
Academic Article Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Academic Article Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
Academic Article Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial.
Academic Article Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Academic Article Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
Academic Article Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
Academic Article Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
Academic Article The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
Academic Article Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
Academic Article Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.
Academic Article Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
Academic Article Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
Academic Article Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
Academic Article Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
Academic Article Risk of haemorrhage associated with long term anticoagulant therapy.
Academic Article Hemorrhagic complications of anticoagulant treatment.
Academic Article A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
Academic Article Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
Academic Article Abelacimab for Prevention of Venous Thromboembolism.
Academic Article Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
Academic Article Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
Academic Article Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Academic Article Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
Academic Article Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
Academic Article Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
Academic Article Redefining clinical venous thromboembolism phenotypes: a?novel approach using latent class analysis.
Academic Article Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer.
Search Criteria
  • Hemorrhage